Subtype
Malignant Pharyngeal Neoplasm
CI-CAN-00003219Explore in graph →
411 active trials1 approved drugs2 evidence items
- NCIt
- C7545
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003219Explore in graph →
Clinical trials
1,255 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (112)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03668366 | S-1 Combined With IMRT Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma | completed | Phase 2 | 133 | Fudan UniversityOTHER | 1 | Feb 11, 2021 | clinicaltrials |
| NCT02636231 | Endostar for Locally Recurrent Nasopharyngeal Carcinoma | unknown | Phase 2 | 96 | Sun Yat-sen UniversityOTHER | 1 | Feb 3, 2021 | clinicaltrials |
| NCT01817023 |
| The Role of Concurrent Chemotherapy for Lower Risk Locally Advanced Nasopharyngeal Carcinoma(NPC) in the Era of IMRT |
| unknown |
| Phase 3 |
| 590 |
| Chinese Academy of Medical SciencesOTHER |
| 1 |
| Jan 29, 2021 |
| clinicaltrials |
| NCT03558035 | New Strategy of Improving Treatment Outcome and Larynx-preservation Rate in Locally Advanced Hypopharyngeal Carcinoma | unknown | Phase 2 | 96 | Chinese Academy of Medical SciencesOTHER | 1 | Jan 29, 2021 | clinicaltrials |
| NCT03874572 | Allogeneic Mesenchymal Stem Cells for Radiation-induced Hyposalivation and Xerostomia/Dry Mouth(MESRIX-SAFETY) | unknown | Phase 1 | 10 | Rigshospitalet, DenmarkOTHER | 1 | Jan 29, 2021 | clinicaltrials |
| NCT03908372 | Optimized Treatment Strategies for Early and Medium Stage Nasopharyngeal Carcinoma | unknown | Phase 2 / Phase 3 | 120 | Chinese Academy of Medical SciencesOTHER | 1 | Jan 29, 2021 | clinicaltrials |
| NCT03915132 | Nimotuzumab Combined With VMAT in Elderly Patients With Nasopharyngeal Carcinoma | unknown | Phase 2 | 47 | Chinese Academy of Medical SciencesOTHER | 1 | Jan 29, 2021 | clinicaltrials |
| NCT03435471 | Outcomes of Prophylactic Swallowing Therapy in Patients Undergoing Definitive Chemoradiation for Head and Neck Cancer | completed | N/A | 30 | University of MiamiOTHER | 1 | Jan 27, 2021 | clinicaltrials |
| NCT01663259 | Reduced-intensity Therapy for Oropharyngeal Cancer in Non-smoking HPV-16 Positive Patients | completed | N/A | 43 | University of Michigan Rogel Cancer CenterOTHER | 1 | Jan 19, 2021 | clinicaltrials |
| NCT04440618 | Prevalence of Obstructive Sleep Apnea Hypopnea Syndrome (OSAHS) Following Squamous Cell Carcinomas of the Oropharynx Treatment by Combined Chemoradiotherapy(COROSAS) | unknown | — | 30 | Poitiers University HospitalOTHER | 1 | Jan 14, 2021 | clinicaltrials |
| NCT00490282 | A Pilot Trial of Image-Guided Adaptive Radiotherapy for Head and Neck Cancer | completed | N/A | 25 | M.D. Anderson Cancer CenterOTHER | 1 | Dec 30, 2020 | clinicaltrials |
| NCT00662662 | Sexual Behavior in Head and Neck Cancer Patients | unknown | — | 1,500 | M.D. Anderson Cancer CenterOTHER | 1 | Dec 30, 2020 | clinicaltrials |
| NCT03601390 | Combining PET/CT and EBV DNA to Evaluate the Hazard of Progression in the Follow-up of Locally Advanced NPC | completed | — | 387 | Sun Yat-sen UniversityOTHER | 1 | Dec 19, 2020 | clinicaltrials |
| NCT02934724 | Impact of HPV Vaccine On The Prevalence Of HPV In Norway | completed | — | 315 | Oslo University HospitalOTHER | 1 | Dec 14, 2020 | clinicaltrials |
| NCT02586532 | Evaluation of the Sensitivity of Endoscopy to Detect Nasopharyngeal Carcinoma (NPC) in an Epstein-Barr Virus (EBV)-Based NPC Screening Project in China | completed | — | 828 | National Cancer Institute (NCI)NIH | 1 | Dec 11, 2020 | clinicaltrials |
| NCT00011492 | Patient Evaluation for Head and Neck Surgery Branch Studies | terminated | — | 62 | National Institute on Deafness and Other Communication Disorders (NIDCD)NIH | 1 | Nov 27, 2020 | clinicaltrials |
| NCT03479463 | Use of Human Dehydrated Amnion Chorion Allograft in Laryngectomy/Pharyngectomy | terminated | — | 8 | MiMedx Group, Inc.INDUSTRY | 1 | Nov 13, 2020 | clinicaltrials |
| NCT04627961 | A Trial of LONSURF in Recurrent/Metastatic Nasopharyngeal Carcinoma | unknown | Phase 2 | 33 | National University Hospital, SingaporeOTHER | 1 | Nov 13, 2020 | clinicaltrials |
| NCT04231864 | Durvalumab and Epacadostat for Treatment of Unresectable, Recurrent, or Metastatic Epstein-Barr Virus Positive Nasopharyngeal Cancer | withdrawn | Phase 2 | 0 | Alain AlgaziOTHER | 0 | Oct 26, 2020 | clinicaltrials |
| NCT03656250 | Assessment of Treatment Response of Nasopharyngeal Cancer Using Simultaneous 18F-FDG-PET and MRI | completed | — | 17 | NYU Langone HealthOTHER | 1 | Oct 19, 2020 | clinicaltrials |
| NCT03890783 | Functional Results of Soft Palate Free Flap Reconstruction(RECaVoLL) | completed | — | 29 | Hospices Civils de LyonOTHER | 1 | Oct 14, 2020 | clinicaltrials |
| NCT03025854 | Prospective Study for Prognostic Biomarkers of Nasopharyngeal Carcinoma | unknown | — | 600 | Sun Yat-sen UniversityOTHER | 1 | Oct 12, 2020 | clinicaltrials |
| NCT04387266 | To Evaluate the Efficacy and Feasibility of Modified Reduce-volume Target IMRT in the Treatment of Patients With Non-metastatic NPC | completed | — | 471 | Fujian Cancer HospitalOTHER_GOV | 1 | Oct 9, 2020 | clinicaltrials |
| NCT03049280 | Prospective, Multicenter da Vinci® SP™ Surgical System TORS Study | completed | N/A | 33 | Intuitive SurgicalINDUSTRY | 1 | Oct 6, 2020 | clinicaltrials |
| NCT04448522 | Reduced vs Conventional Dosage Intensity-modulated Radiotherapy for Chemotherapy-sensitive Stage II-III Nasopharyngeal Carcinoma | recruiting | Phase 3 | 508 | Sun Yat-sen UniversityOTHER | 2 | Sep 28, 2020 | clinicaltrials |
| NCT04453813 | Toripalimab Plus Concurrent Chemo-radiotherapy for Unresectable Locally Recurrent Nasopharyngeal Carcinoma | recruiting | Phase 3 | 226 | Sun Yat-sen UniversityOTHER | 1 | Sep 28, 2020 | clinicaltrials |
| NCT04453826 | Concurrent and Adjuvant PD1 Treatment Combined With Chemo-radiotherapy for High-risk Nasopharyngeal Carcinoma | recruiting | Phase 3 | 388 | Sun Yat-sen UniversityOTHER | 1 | Sep 28, 2020 | clinicaltrials |
| NCT03048305 | Prospective Study for Molecular Biomarkers of Normal Nasopharyngeal Tissue | unknown | — | 200 | Sun Yat-sen UniversityOTHER | 1 | Sep 25, 2020 | clinicaltrials |
| NCT03129412 | Oligo-metastases NPC Patients Received Radiation for Primary Tumors and Treatments for Metastatic Lesions | unknown | Phase 2 | 64 | Zhejiang Cancer HospitalOTHER | 1 | Sep 17, 2020 | clinicaltrials |
| NCT04553510 | Treatment of Bevacizumab Followed by Steroid in RN | unknown | Phase 2 | 86 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Sep 17, 2020 | clinicaltrials |
| NCT04547088 | Camrelizumab Combined With Apatinib in Patients With First-line Platinum-resistant Recurrent/Metastatic Nasopharyngeal Carcinoma | unknown | Phase 2 | 27 | Sun Yat-sen UniversityOTHER | 1 | Sep 14, 2020 | clinicaltrials |
| NCT04548271 | Camrelizumab Combined With Apatinib in Patients With PD-1 Antagonists Resistant Recurrent/Metastatic Nasopharyngeal Carcinoma | unknown | Phase 2 | 25 | Sun Yat-sen UniversityOTHER | 1 | Sep 14, 2020 | clinicaltrials |
| NCT04220749 | Radiotherapy vs. Trans-Oral Surgery for HPV-Negative Oropharyngeal Squamous Cell Carcinoma | recruiting | Phase 2 | 68 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sOTHER | 1 | Sep 4, 2020 | clinicaltrials |
| NCT04538547 | Randomized Trial to Evaluate Accelerated Radiotherapy in Locally Advanced Carcinoma of Nasopharynx(EARN) | unknown | N/A | 120 | Post Graduate Institute of Medical Education and Research, ChandigarhOTHER | 1 | Sep 4, 2020 | clinicaltrials |
| NCT03989297 | PD-L1 and BRAF Expression in Nasopharyngeal Carcinoma | completed | — | 104 | Kiang Wu HospitalOTHER | 1 | Sep 2, 2020 | clinicaltrials |
| NCT04534855 | A Phase II Clinical Study of Treprilimab in the Treatment of Recurrent Nasopharyngeal Carcinoma After Re-irradiation | unknown | Phase 2 | 40 | Sun Yat-sen UniversityOTHER | 0 | Sep 1, 2020 | clinicaltrials |
| NCT02476669 | Serial Plasma EBV DNA for Nasopharyngeal Carcinoma | unknown | — | 900 | The University of Hong KongOTHER | 1 | Aug 14, 2020 | clinicaltrials |
| NCT03648697 | EBV-TCR-T（YT-E001）for Patients With EBV-positive Recurrent or Metastatic NPC | unknown | Phase 2 | 20 | Fujian Cancer HospitalOTHER_GOV | 1 | Aug 11, 2020 | clinicaltrials |
| NCT03720340 | Interleukin-11 Can Prevent and Treat of Radioactive Oral Mucitis | unknown | Phase 3 | 300 | Zhejiang Cancer HospitalOTHER | 1 | Aug 11, 2020 | clinicaltrials |
| NCT01314755 | A Trial of Perioperative Immune Enhancing Feed in Patients Undergoing Surgery for Head and Neck Cancer(IMPACTHN) | completed | N/A | 76 | Terrence JonesOTHER_GOV | 1 | Aug 7, 2020 | clinicaltrials |
| NCT04502641 | Induction Chemotherapy in Locally Advanced Hypopharyngeal Carcinoma: a Randomised Phase 3 Trial | unknown | Phase 3 | 160 | Sun Yat-sen UniversityOTHER | 1 | Aug 6, 2020 | clinicaltrials |
| NCT02575547 | Effect of Chemoradiotherapy on Nutritional Status in Advanced NPC Patients | completed | — | 186 | Zhao ChongOTHER | 1 | Jul 30, 2020 | clinicaltrials |
| NCT01249443 | Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection | terminated | Phase 1 | 17 | AIDS Malignancy ConsortiumNETWORK | 1 | Jul 29, 2020 | clinicaltrials |
| NCT04292990 | Comparison of Transdermal Fentanyl and Morphine for Oral Mucositis Pain in Nasopharyngeal Cancer Patients | unknown | Phase 4 | 300 | Jiarong Chen, MDOTHER | 0 | Jul 29, 2020 | clinicaltrials |
| NCT04472403 | Platinum Plus Low-dose Long-term Continuous Intravenous Infused 5-Fluorouracil in Metastatic Nasopharyngeal Carcinoma | unknown | — | 2,000 | Sun Yat-sen UniversityOTHER | 1 | Jul 20, 2020 | clinicaltrials |
| NCT04476641 | A Study of DC-CIK Immunotherapy in the Treatment of Solid Tumors(DC-CIK) | unknown | Phase 2 | 686 | Sun Yat-sen UniversityOTHER | 1 | Jul 20, 2020 | clinicaltrials |
| NCT01187238 | The Value of Concurrent Chemoradiotherapy for Stage II Nasopharyngeal Carcinoma | completed | Phase 2 | 84 | Chinese Academy of Medical SciencesOTHER | 1 | Jul 16, 2020 | clinicaltrials |
| NCT04447326 | Toripalimab, Endostar Combined With Radiotherapy and Chemotherapy for Nasopharyngeal Carcinoma | unknown | Phase 2 | 106 | First Affiliated Hospital of Guangxi Medical UniversityOTHER | 0 | Jun 25, 2020 | clinicaltrials |
| NCT04447612 | Concurrent Chemoradiation and Durvalumab for Locoregionally Advanced Nasopharyngeal Carcinoma | unknown | Phase 2 | 118 | The University of Hong KongOTHER | 1 | Jun 25, 2020 | clinicaltrials |
| NCT00341146 | Molecular Genetics Study of Nasopharyngeal Carcinoma: Characterization of NCP Susceptibility Gene(s) | completed | — | 6,490 | National Cancer Institute (NCI)NIH | 1 | Jun 16, 2020 | clinicaltrials |
Data updated 24 days agoSource updated Feb 11, 2021source: clinicaltrials